{"organizations": [], "uuid": "d8e447024dc274dbeb02fa5d6aa140b1cc6b9e33", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/05/10/the-associated-press-depomed-1q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Depomed: 1Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-10T17:31:00.000+03:00", "replies_count": 0, "uuid": "d8e447024dc274dbeb02fa5d6aa140b1cc6b9e33"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/05/10/the-associated-press-depomed-1q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Depomed: 1Q Earnings Snapshot", "locations": [], "entities": {"persons": [], "locations": [{"name": "newark", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "newark", "sentiment": "none"}], "organizations": [{"name": "depomed inc.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NEWARK, Calif. (AP) _ Depomed Inc. (DEPO) on Thursday reported first-quarter net income of $33.8 million, after reporting a loss in the same period a year earlier.\nThe Newark, California-based company said it had net income of 48 cents per share. Earnings, adjusted for non-recurring gains, were 28 cents per share.\nThe results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 14 cents per share.\nThe drugmaker posted revenue of $128.4 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $62.5 million.\nDepomed shares have decreased 26 percent since the beginning of the year. The stock has fallen 46 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on DEPO at https://www.zacks.com/ap/DEPO", "external_links": ["https://www.zacks.com/ap/DEPO", "http://automatedinsights.com/ap"], "published": "2018-05-10T17:31:00.000+03:00", "crawled": "2018-05-10T16:51:27.002+03:00", "highlightTitle": ""}